CLABSI

CLABSI

Central Line Associated Blood Stream Infections (CLABSI) are infections in the bloodstream developed within 48 hours of the placement of a central line and not related to another infection site.

Resources

  1. https://www.cdc.gov/hai/bsi/bsi.html

Australia:

  • Approximately 4000 episodes in Australian intensive care units each year. Mortality rate of 4–20% with estimated cost of $36.26 million

Europe:

  • additional associated costs of a CR-BSI episode in Europe ranged from €4,200 to €13,030, representing annual costs to healthcare systems of €54 million in the United Kingdom and €130 million in France2

US:

  • CLABSI is associated with thousands of deaths and billions of dollars each year in the US, making it one of the deadliest and most costly HAIs.3
  • It is estimated that treatment for CLABSI can range from 7 days to 6 weeks and cost an average of roughly $46,000 per case.4
  • Despite treatment for CLABSI, it is estimated that 25% of people who contract a CLABSI will die.5

Resources

  1. https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.13642
  2. http://info.debgroup.com/blog/bid/323079/what-is-the-cost-of-healthcare-associated-infections
  3. https://www.cdc.gov/hai/bsi/bsi.html
  4. http://journals.sagepub.com/doi/pdf/10.1177/2158244016677747
  5. https://www.beckershospitalreview.com/quality/the-positive-roi-on-clabsi-prevention-interventions.html